Major depressive disorder in the elderly is associated with increased morbidity and reduced quality of life. This 10 week, placebo-controlled study investigated the efficacy and tolerability of extended-release bupropion (150—300 mg once daily) in depressed patients aged 65 years or older. The statistical assumptions necessary for the validity of the protocol-specified analysis of covariance were not met for the analysis of the primary outcome variable (Montgomery-Asberg Depression Rating Scale total score at Week 10, last observation carried forward). Alternative statistical methods used for the analysis of this variable demonstrated statistical significance. Statistically significant improvements were observed on the majority of secondary end points when compared with placebo, including the health outcome measures for motivation and energy, and life satisfaction and contentment. Adverse events were generally mild to moderate and similar between treatment groups. This study demonstrated that the extended-release bupropion is an effective, well-tolerated treatment for major depression in the elderly.
Alexopoulos, GS, Vrontou, C., Kakuma, T., Meyers, BS, Young, RC, Klausner, E., et al. (1996) Disability in geriatric depression. Am J Psychiatry153: 877-885.
2.
Beaton, AE, Tukey, JW ( 1974) The fitting of power series, meaning polynomials, illustrated on bend-spectroscopic data. Technometrics16: 147-185.
3.
Beekman, AT, Copeland, JR, Prince, MJ (1999) Review of community prevalence of depression in later life. Br J Psychiatry 174: 307-311. Blazer, DG (2003) Depression in late life: review and commentary. J Gerontol A Biol Sci Med Sci 58: 249-265.
4.
Branconnier, RJ, Cole, JO, Ghazvinian, S., Spera, KF, Oxenkrug, GF, Bass, JL ( 1983) Clinical pharmacology of bupropion and imipramine in elderly depressives. J Clin Psychiatry44: 130-133.
5.
Charney, DS, Reynolds 3rd, CF, Lewis, L., Lebowitz, BD, Sunderland, T., Alexopoulos, GS, et al. (2003) Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry60: 664-672.
6.
Doraiswamy, PM, Khan, ZM, Donahue, RM, Richard, NE ( 2001) Quality of life in geriatric depression: a comparison of remitters, partial responders, and nonresponders. Am J Geriatr Psychiatry9: 423-428.
7.
Draper, BM, Koschera, A. ( 2001) Do older people receive equitable private psychiatric service provision under Medicare. Aust N Z J Psychiatry35: 626-630.
8.
Endicott, J. ( 2000) Quality of life enjoyment and satisfaction questionnaire (Q-LES-Q). In: Rush AJ, Handbook of psychiatric measures. Washington, DC: American Psychiatric Association, pp. 143-144.
9.
Fava, M., Rush, AJ, Thase, ME, Clayton, A., Stahl, SM, Pradko, JF, et al. (2005) 15 years of clinical experience with bupropion HCl: from bupropion to bupropion SR to bupropion XL. Prim Care Companion J Clin Psychiatry7: 106-113.
10.
Fehnel, SE, Bann, CM, Hogue, SL, Kwong, WJ, Mahajan, SS ( 2004) The development and psychometric evaluation of the Motivation and Energy Inventory (MEI). Qual Life Res13: 1321-1336.
11.
Fortner, MR, Brown, K., Varia, IM, Gersing, KR, OConnor, C., Doraiswamy, PM ( 1999) Effect of bupropion SR on the quality of life of elderly depressed patients with comorbid medical disorders. Prim Care Companion J Clin Psychiatry1: 174-179.
12.
Granger, AL, Fehnel, SE, Hogue, SL, Bennett, L., Edin, HM ( 2006) An assessment of patient preference and adherence to treatment with Wellbutrin SR: a web-based survey. J Affect Disord90: 217- 221.
13.
Huang, BY, Cornoni-Huntley, J., Hays, JC, Huntley, RR, Galanos, AN, Blazer, DG ( 2000) Impact of depressive symptoms on hospitalization risk in community-dwelling older persons. J Am Geriatr Soc48: 1279-1284.
14.
Jefferson, JW, Rush, AJ, Nelson, JC, VanMeter, SA, Krishen, A., Hampton, KD, et al. (2006) Extended-release bupropion for patients with major depressive disorder presenting with symptoms of reduced energy, pleasure, and interest: findings from a randomized, double-blind, placebo-controlled study. J Clin Psychiatry67: 865-873.
15.
Kasper, S., de Swart, H., Andersen, HF ( 2005) Escitalopram in the treatment of depressed elderly patients . Am J Geriatr Psychiatry13: 884-891.
16.
Lebowitz, BD, Pearson, JL, Schneider, LS, Reynolds 3rd, CF, Alexopoulos, GS, Bruce, ML, et al. (1997) Diagnosis and treatment of depression in late life. Consensus statement update. JAMA278: 1186-1190.
17.
Modell, JG, Rosenthal, NE, Harriett, AE, Krishen, A., Asgharian, A., Foster, VJ, et al. (2005) Seasonal affective disorder and its prevention by anticipatory treatment with bupropion XL. Biol Psychiatry58: 658-667.
18.
Quade, D. ( 1967) Rank analysis of covariance. J Am Stat Assoc62: 1187-1200.
19.
Rapaport, MH, Schneider, LS, Dunner, DL, Davies, JT, Pitts, CD ( 2003) Efficacy of controlled-release paroxetine in the treatment of late-life depression. J Clin Psychiatry64: 1065-1074.
20.
Roose, SP, Sackeim, HA, Krishnan, KR, Pollock, BG, Alexopoulos, G., Lavretsky, H., et al. (2004) Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry161: 2050-2059.
21.
Schaefer, D., Pitts, C., Lipschitz, A., Iyengar, M. ( 2005) Efficacy and tolerability of fixed low dose paroxetine CR in the treatment of major depression in the elderly. American Psychiatric Association; Abstract NR 701.
22.
Schatzberg, AF, Cantillon, M. ( 2000) Antidepressant early response and remission of venlafaxine and fluoxetine in geriatric patients with major depression. Eur Neuropsychopharmacol10: S225-S226.
23.
Schneider, LS, Nelson, JC, Clary, CM, Newhouse, P., Krishnan, KR, Shiovitz, T., et al. (2003) An 8-week multicenter, parallel-group, double-blind, placebo-controlled study of sertraline in elderly outpatients with major depression . Am J Psychiatry160: 1277-1285.
Sheehan, DV, Harnett-Sheehan, K., Raj, BA ( 1996) The measurement of disability. Int Clin Psychopharmacol11 (Suppl. 3): 89-95.
26.
Stahl, SM ( 2002) Selective actions on sleep or anxiety by exploiting GABA-A/benzodiazepine receptor subtypes. J Clin Psychiatry63: 179-180.
27.
Stahl, SM, Pradko, JF, Haight, BR, Modell, JG, Rockett, CB, Learned-Coughlin, S. ( 2004) A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry6: 159-166.
28.
Thase, ME, Clayton, AH, Haight, BR, Thompson, AH, Modell, JG, Johnston, JA ( 2006) A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. J Clin Psychopharmacol26: 482-488.
29.
Thase, ME, Haight, BR, Richard, N., Rockett, CB, Mitton, M., Modell, JG, et al. (2005) Remission rates following antidepressant therapy with bupropion or selective serotonin reuptake inhibitors: a meta-analysis of original data from 7 randomized controlled trials. J Clin Psychiatry66: 974-981.
30.
Tollefson, GD, Bosomworth, JC, Heiligenstein, JH, Potvin, JH, Holman, S. ( 1995) A double-blind, placebo-controlled clinical trial of fluoxetine in geriatric patients with major depression. The Fluoxetine Collaborative Study Group. Int Psychogeriatr7: 89-104.
31.
Unützer, J., Patrick, DL, Diehr, P., Simon, G., Grembowski, D., Katon, W. ( 2000) Quality adjusted life years in older adults with depressive symptoms and chronic medical disorders. Int Psychogeriatr12: 15-33.
32.
Unützer, J., Patrick, DL, Simon, G., Grembowski, D., Walker, E., Rutter, C., et al. (1997) Depressive symptoms and the cost of health services in HMO patients aged 65 years and older. A 4-year prospective study . JAMA277: 1618-1623.
33.
Weihs, KL, Houser, TL, Batey, SR, Ascher, JA, Bolden-Watson, C., Donahue, RM, et al. (2002) Continuation phase treatment with bupropion SR effectively decreases the risk for relapse of depression. Biol Psychiatry51: 753-761.
34.
Weihs, KL, Settle Jr, EC, Batey, SR, Houser, TL, Donahue, RM, Ascher, JA ( 2000) Bupropion sustained release versus paroxetine for the treatment of depression in the elderly. J Clin Psychiatry61: 196-202.
35.
Zubenko, GS, Mulsant, BH, Sweet, RA, Pasternak, RE, Tu, XM ( 1997) Mortality of elderly patients with psychiatric disorders . Am J Psychiatry154: 1360-1368.
